Hospice Industry: Regulation tightens as operators chase growth

• The hospice industry is facing three converging forces: tighter regulatory scrutiny, pressure on operating margins, and a shift toward identifying appropriate patients earlier in their care journey.
• CMS increased FY 2027 hospice reimbursement by 2.3%, but rising labor and administrative costs continue to pressure profitability, making operational efficiency increasingly important.^[1]
• CMS finalized the nine-measure Service and Spending Variation Index (SSVI) to describe variation in hospice utilization and non-hospice Medicare spending. It could draw attention to atypical patterns, although a high score alone does not establish wrongdoing.^[2]
• DOJ and HHS launched a six-month healthcare self-disclosure pilot. Qualifying providers can resolve certain False Claims Act matters through a coordinated process with repayment calculated using a 1.25–1.6 multiplier. This raises the value of identifying and correcting compliance problems early.^[3]
• CommonSpirit Health at Home says the Medicare hospice enrollment moratorium disrupted its de novo expansion plans, prompting a pivot toward growth in existing markets and earlier identification of appropriate patients.^[4]
• Elara Caring reports that about 20% of its hospice referrals come from its home health operations, illustrating a possible advantage of serving patients across more of the care continuum.^[5]
• This suggests the next competitive advantage may depend less on generating referrals alone and more on identifying patients who need a different level of care and transitioning them efficiently.
• California hospices reported about $4.57 million in outstanding Medicaid room-and-board reimbursements across 18 survey responses, showing that cash collection problems can strain providers even after services have been delivered.^[6]
• A 2026 palliative care survey found that 73.7% of respondents saw consultation volume increase, while only 39% of team leaders reported staffing increases. That points to pressure to improve clinical productivity without proportional hiring.^[7]
• The AI conversation is shifting from what software can generate to whether clinicians can trust its outputs, assess the evidence, and fit tools into established workflows.^[8]
• Medicare's FY 2027 routine home care base rate is $236.33 per day for days 1–60 and $186.33 thereafter, before geographic wage adjustment. Length of stay, clinical utilization, and cost per admission therefore remain important to hospice economics.^[1]

Sources

1. CMS, Hospice Payments: FY 2027 Update. FY 2027 standardized routine home care base rates; local payment is adjusted by the applicable wage index.
2. CMS, Service and Spending Variation Index (SSVI) Overview.
3. HHS and DOJ, Healthcare False Claims Act Self-Disclosure Pilot Program, October 22, 2026.
4. Hospice News, CommonSpirit Health at Home’s 3 Pillars for Hospice Growth, October 23, 2026.
5. Hospice News interview with Elara Caring board chair Paul Kusserow, October 21, 2026.
6. Hospice News, Medicaid Plans Failing to Reimburse Hospices for Nursing Home Room-and-Board, October 20, 2026.
7. Center to Advance Palliative Care, 2026 Palliative Pulse Survey findings.
8. Hospice Care in the Era of AI: Hospices’ Views on Data-Driven Tools to Support Live Discharge Decisions, Journal of the American Geriatrics Society, 2026.